Biography

Taya Bokert is an associate in Weil’s Technology & IP Transactions practice and is based in New York. Taya participates in advising Firm clients in a variety of matters relating to the licensing, acquisition, development, sale, use and commercial exploitation of intellectual property and technology. She also participates in advising clients regarding privacy and data security issues in the context of corporate transactions.
Taya has been part of the teams advising:
- Midwest Fiber Holdings LP in its entry into a $285 million stalking horse asset purchase agreement with Bluebird MidWest, LLC, an affiliate of Bluebird Fiber, in connection with its chapter 11 proceedings
- Sanofi in its $9.5 billion acquisition of Blueprint Medicines
- TCV in its investment in Cloudsmith Inc.
Taya received her J.D., magna cum laude, from Fordham University School of Law where she was a Fordham Law Review Member, Pro Bono Scholar and member of the Alpha Sigma Nu Honor Society. She received her B.A., cum laude, from Washington University in St. Louis.
Awards and Recognition, Speaking Engagements, Guides and Resources, Latest Thinking, Firm News & Announcements
Latest Thinking
- Cyber Health Checkup for 2025 Publication — New York Law Journal — By Olivia J. Greer and Taya Bokert — PDF — March 03, 2025
Firm News & Announcements
- Weil Advises Sanofi in its $9.5 Billion Acquisition of Blueprint Medicines Deal Brief — June 02, 2025
- Weil Advises WhiteHawk in Acquisition of PHX Minerals Deal Brief — May 08, 2025